Paroxysmal Nocturnal Hemoglobinuria
![Danicopan Shows Promise as an Add-On to Ultomiris or Soliris, Enhancing Hemoglobin Levels and Disease Control in PNH Patients](https://pharmtales.com/wp-content/uploads/2023/06/Danicopan-Shows-Promise-as-an-Add-On-to-Ultomiris-or-Soliris-Enhancing-Hemoglobin-Levels-and-Disease-Control-in-PNH-Patients-with-Extravascular-Hemolysis-Symptoms.jpg)
Danicopan Shows Promise as an Add-On to Ultomiris or Soliris, Enhancing Hemoglobin Levels and Disease Control in PNH Patients
SG Tylor
Source – AstraZeneca Promising outcomes emerged from the pivotal Phase III ALPHA trial, revealing that danicopan, an investigational oral Factor ...